We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Embryonal Rhabdomyosarcoma?

By Stephany Seipel
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Embryonal rhabdomyosarcoma is a rapidly growing, highly malignant type of cancer that normally affects children who are younger than 15 years old. This type of tumor is particularly aggressive and has a tendency to grow back unless it is completely eradicated. The prognosis for survival varies depending upon the age of the child and the location and size of the mass.

In children, embryonal rhabdomyosarcoma is the most common type of soft tissue sarcoma. It occurs when embryonic cells called rhabdomyoblasts, which are the cells that ultimately develop into skeletal muscle tissue, grow out of control and turn into cancerous tumors instead. Rhabdomyosarcoma tumors can grow in nearly any part of the body except for the brain.

This type of cancer usually occurs in four predominant areas of the body. It occurs most often around the head, neck and eyes. Rhabdomyosarcoma tumors might also form in the urinary tract and genital region, the arms and legs or in the lungs and chest.

Males have slightly higher rates of developing this type of cancer than females. Although all races are at risk, Asians are somewhat less susceptible than blacks or whites. The disease does not occur in any specific geographic region.

The symptoms of embryonal rhabdomyosarcoma might include a drooping eyelid or protruding eye if the tumor is located around the eyes. Patients might experience bleeding or pain in the nose, throat or genitalia or might have tingling, pain or a lack of sensation in the affected area. The patient might also have an evident tumor or growth.

The doctor will perform a biopsy to determine whether the patient has cancer. He or she also will perform a number of other tests, such as X-rays, bone scans, a biopsy of the bone marrow and computed tomography (CT) scans. The doctor might also look inside the body by performing ultrasounds or magnetic resonance imaging (MRI) tests. Embryonal rhabdomyosarcoma is treated by surgically removing the tumor, by administering radiation or chemotherapy or through a combination of approaches.

Embryonal rhabdomyosarcoma is the most treatable form of rhabdomyosarcoma, depending on the age of the patient and where the tumor is located. Children younger than 12 months old have a generally poor prognosis. Patients whose tumors are located in the genital area, head and neck have higher survival rates than children whose tumors form in other areas of the body. The prognosis for embryonal rhabdomyosarcoma is generally favorable as long as the cancer has not metastasized, or spread to other areas of the body.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.